Evaluation of Diet and Exercise in Prostate Cancer Patients

Official Title

Canadian Real Life Evaluation of Exercise and Diet in Patients Treated With Lupron® for the Management of Prostate Cancer:(CRONOS II)

Summary:

Canadian Real Life Evaluation of the Effect of Diet and Exercise in Prostate Cancer Patients Managed with Lupron.

Trial Description

Primary Outcome:

  • Changes in the patient quality of life (QoL) using the Medical Outcomes Study Short Form - 36 (SF-36)
Secondary Outcome:
  • Changes in the University of California Los Angeles Prostate Cancer Index (UCLA-PI)
  • Changes in the sexual function using the International Index of Erectile Function (IIEF-5)
  • Changes in the proportion of patients with castrate levels of testosterone and normal levels of Prostatic Specific Antigen (PSA) at 36 months of treatments.
  • Number of patients with Adverse Events
  • Changes in the patient's medical condition
  • Changes in the Doctor-Patient communication
This is a study utilizing a prospective cohort design. Patients with Prostrate cancer (PCa) who are prescribed Lupron will be entered into the study cohort and will be followed for a maximum of 36 months with recommended assessments at 3, 6, 12, 18, 24, 30 and 36 months after Day 1. Treatment of the patients and follow up will be according to the physicians' judgment, regional regulations and the product monograph.

View this trial on ClinicalTrials.gov

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

Resources

Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society